搜尋結果
As Their Clinics Sputter, Walgreens And Walmart Invest More In Specialty Pharmacy
Forbes· 2 日前As Walgreens and Walmart scale back their investments in physician-staffed health clinics, they ...
Amgen investors await weight-loss drug data
Reuters· 1 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
US Senators Introduce Bill To Legalize Marijuana
Forbes· 16 小時前A group of 18 Democratic Senators this week reintroduced a bill to legalize marijuana ... ...
Health Care Roundup: Market Talk
The Wall Street Journal· 8 小時前The latest Market Talks covering the Health Care sector.
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 3 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, ...
CNBC· 2 日前Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 3 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
Forbes Daily: Why ‘Bitcoin Jesus’ Could Be Extradited To The U.S.
Forbes· 16 小時前What if your pharmacist could prescribe your medications? In select cases at pharmacy giants ...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 日前Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling ...
HSBC wealth investor is convinced four secular themes will keep the U.S. economy humming along ...
CNBC· 4 日前"From a business cycle dynamics perspective, the Fed raised rates, nothing happened ... ...